Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicentre, randomised, double-blind study to compare Stalevo to levodopa/carbidopa in Parkinson's disease patients with early wearing-off
2004-005234-39Phase 4Completed
- Sponsor
- Orion Corporation
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of levodopa in Parkinson's disease (PD) (2 arms), sponsored by Orion Corporation. Primary endpoint: Time to need for increased antiparkinsonian therapy. Started Mar 2005; status: completed.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2004-005234-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005234-39.